X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (6765) 6765
Publication (886) 886
Newsletter (138) 138
Book Review (32) 32
Book Chapter (22) 22
Newspaper Article (16) 16
Magazine Article (10) 10
Dissertation (5) 5
Conference Proceeding (3) 3
Web Resource (3) 3
Paper (2) 2
Data Set (1) 1
Journal / eJournal (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (3922) 3922
ceftazidime (3408) 3408
microbiology (1928) 1928
male (1860) 1860
female (1818) 1818
pharmacology & pharmacy (1664) 1664
microbial sensitivity tests (1568) 1568
index medicus (1502) 1502
ceftazidime - pharmacology (1466) 1466
ceftazidime - therapeutic use (1397) 1397
infectious diseases (1392) 1392
adult (1265) 1265
anti-bacterial agents - pharmacology (1255) 1255
middle aged (1215) 1215
antibiotics (1083) 1083
anti-bacterial agents - therapeutic use (1043) 1043
aged (972) 972
infections (727) 727
pseudomonas aeruginosa - drug effects (722) 722
ceftazidime - administration & dosage (694) 694
adolescent (673) 673
cephalosporins - pharmacology (653) 653
resistance (572) 572
animals (560) 560
cephalosporins - therapeutic use (535) 535
bacteria (519) 519
beta-lactamases - metabolism (517) 517
child (507) 507
beta-lactamases - genetics (506) 506
bacterial infections - drug therapy (499) 499
anti-bacterial agents - administration & dosage (496) 496
pseudomonas aeruginosa (482) 482
escherichia-coli (481) 481
treatment outcome (478) 478
pseudomonas infections - drug therapy (474) 474
drug therapy, combination (456) 456
cefepime (440) 440
pseudomonas-aeruginosa (439) 439
drug resistance, microbial (434) 434
cephalosporins (432) 432
enterobacteriaceae (421) 421
ciprofloxacin (400) 400
pharmacokinetics (399) 399
prospective studies (394) 394
imipenem (387) 387
research article (386) 386
therapy (386) 386
aged, 80 and over (376) 376
meropenem (374) 374
klebsiella-pneumoniae (371) 371
escherichia coli - drug effects (361) 361
drug resistance (351) 351
child, preschool (344) 344
biochemical phenomena, metabolism, and nutrition (343) 343
cefotaxime (340) 340
immunology (330) 330
research (324) 324
infection (323) 323
oncology (322) 322
ceftazidime - pharmacokinetics (321) 321
gram-negative bacteria (313) 313
fever (303) 303
epidemiology (298) 298
gram-negative bacteria - drug effects (298) 298
antimicrobial agents (295) 295
pneumonia (289) 289
infant (288) 288
polycyclic compounds (288) 288
amikacin (285) 285
health aspects (285) 285
klebsiella pneumoniae - drug effects (285) 285
susceptibility (285) 285
ceftazidime - adverse effects (284) 284
bacterial infections and mycoses (277) 277
drug resistance, bacterial (268) 268
risk factors (268) 268
cefotaxime - pharmacology (267) 267
hospitals (265) 265
drug therapy, combination - therapeutic use (263) 263
anti-bacterial agents - pharmacokinetics (262) 262
enterobacteriaceae - drug effects (261) 261
pediatrics (260) 260
ceftriaxone (255) 255
gentamicin (255) 255
kinetics (254) 254
pseudomonas infections - microbiology (252) 252
ceftazidime-avibactam (251) 251
vancomycin (249) 249
bacteremia (248) 248
antimicrobial resistance (245) 245
imipenem - pharmacology (245) 245
infusions, intravenous (244) 244
retrospective studies (242) 242
drug resistance in microorganisms (240) 240
medicine, general & internal (239) 239
bacteria - drug effects (238) 238
cephalosporins - administration & dosage (238) 238
strains (229) 229
time factors (227) 227
antibiotic resistance (226) 226
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (6264) 6264
French (216) 216
Japanese (131) 131
Spanish (66) 66
German (62) 62
Chinese (56) 56
Italian (56) 56
Russian (32) 32
Polish (21) 21
Turkish (19) 19
Romanian (6) 6
Croatian (5) 5
Czech (5) 5
Hungarian (4) 4
Korean (4) 4
Portuguese (4) 4
Slovak (3) 3
Arabic (2) 2
Danish (2) 2
Dutch (2) 2
Lithuanian (2) 2
Bosnian (1) 1
Bulgarian (1) 1
Finnish (1) 1
Indonesian (1) 1
Persian (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal Article
Journal Article
American Journal of Respiratory and Critical Care Medicine, ISSN 1073-449X, 07/2011, Volume 184, Issue 1, pp. 106 - 115
Journal Article
Journal of Molecular Liquids, ISSN 0167-7322, 02/2019, Volume 276, p. 970
In the previous work, cyclic Voltammetry studies of (bulk/or nano) CdCl.sub.2 (BCC and NCC) in (presence/or absence) of Ceftazidime are performed to predict... 
Thermodynamics | Electrochemical reactions | Ceftazidime
Journal Article
Current Medical Research & Opinion, ISSN 0300-7995, 12/2012, Volume 28, Issue 12, pp. 1921 - 1931
Journal Article
Asian Journal of Pharmaceutical and Clinical Research, ISSN 0974-2441, 2018, Volume 11, Issue 3, pp. 47 - 50
Objective: The present study was undertaken to investigate the photohemolysis reaction through photosensitization reaction by ceftazidime as a photosensitizer... 
Photosensitization | Photosensitizer | Photohemolysis | Ceftazidime
Journal Article
Biochemistry, ISSN 0006-2960, 07/2017, Volume 56, Issue 27, pp. 3443 - 3453
CTX-M beta-lactamases provide resistance against the beta-lactam antibiotic, cefotaxime, but not a related antibiotic, ceftazidime. beta-Lactamases that carry... 
M ENZYMES | ANGSTROM RESOLUTION | SUBSTITUTION | EXTENDED-SPECTRUM | OMEGA-LOOP | CATALYTIC-PROPERTIES | GLOBAL SUPPRESSOR | BIOCHEMISTRY & MOLECULAR BIOLOGY | HYDROLYSIS | CEFTAZIDIME RESISTANCE | PEPTIDE-BOND | Ceftazidime - pharmacology | Escherichia coli - drug effects | Cephalosporins - chemistry | Substrate Specificity | Crystallography, X-Ray | Ceftazidime - metabolism | beta-Lactamases - genetics | Oximes - metabolism | Anti-Bacterial Agents - chemistry | Drug Resistance, Multiple, Bacterial | Apoenzymes - metabolism | Ceftazidime - chemistry | beta-Lactamases - metabolism | Cephalosporins - pharmacology | Acylation | Recombinant Proteins - metabolism | Catalytic Domain | Escherichia coli - enzymology | Mutagenesis, Site-Directed | Enzyme Stability | Models, Molecular | Recombinant Proteins - chemistry | Anti-Bacterial Agents - metabolism | Escherichia coli Proteins - metabolism | Hydrolysis | Oximes - chemistry | Point Mutation | beta-Lactamases - chemistry | Apoenzymes - genetics | Apoenzymes - chemistry | Escherichia coli Proteins - genetics | Oximes - pharmacology | Ligands | Protein Conformation | Anti-Bacterial Agents - pharmacology | Escherichia coli Proteins - chemistry | Amino Acid Substitution | Cephalosporins - metabolism | Moxalactam | Cephalosporins | Analysis | Beta lactamases | Cephaloridine | Research | INORGANIC, ORGANIC, PHYSICAL, AND ANALYTICAL CHEMISTRY
Journal Article
Journal Article
Journal Article
Expert Opinion on Pharmacotherapy, ISSN 1465-6566, 11/2016, Volume 17, Issue 17, pp. 2341 - 2349
Introduction: The treatment of complicated intra-abdominal infections (cIAI) is increasingly challenging due to increased resistance of Gram-negative... 
complicatedintra-abdominal infections | β-lactam-β-lactamase inhibitors | ceftazidime-avibactam | Antibiotic resistance | ANTIMICROBIAL SUSCEPTIBILITY | PLUS METRONIDAZOLE | LACTAMASE INHIBITOR COMBINATION | DISEASES SOCIETY | DOUBLE-BLIND | CHILDREN GUIDELINES | PHARMACOLOGY & PHARMACY | SPECTRUM BETA-LACTAMASES | CRITICALLY-ILL PATIENTS | IN-VITRO ACTIVITY | KLEBSIELLA-PNEUMONIAE | beta-lactam-beta-lactamase inhibitors | Bacterial Proteins - antagonists & inhibitors | Enterobacteriaceae - enzymology | Klebsiella pneumoniae - drug effects | Intraabdominal Infections - microbiology | Azabicyclo Compounds - administration & dosage | Humans | Gram-Negative Bacterial Infections - drug therapy | beta-Lactamase Inhibitors - administration & dosage | beta-Lactamase Inhibitors - pharmacokinetics | Ceftazidime - pharmacokinetics | Gram-Negative Bacterial Infections - microbiology | beta-Lactamase Inhibitors - adverse effects | Metronidazole - therapeutic use | beta-Lactamase Inhibitors - therapeutic use | Ceftazidime - administration & dosage | Enterobacteriaceae - drug effects | Klebsiella pneumoniae - enzymology | Azabicyclo Compounds - therapeutic use | Azabicyclo Compounds - pharmacokinetics | Ceftazidime - adverse effects | beta-Lactamases - metabolism | Intraabdominal Infections - drug therapy | Ceftazidime - therapeutic use | Azabicyclo Compounds - adverse effects
Journal Article
Critical Care, ISSN 1364-8535, 07/2010, Volume 14, Issue 4, pp. R126 - R126
Journal Article